An Effectiveness and Safety Study for Levofloxacin in Chronic Prostatitis

PHASE3CompletedINTERVENTIONAL
Enrollment

242

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

March 31, 2008

Study Completion Date

September 30, 2008

Conditions
Prostatitis
Interventions
DRUG

levofloxacin

750mg tablet once daily for 2 weeks followed by 2 weeks of placebo.

DRUG

levofloxacin

750mg tablet once daily for 3 weeks followed by 1 week of placebo.

DRUG

levofloxacin

500mg tablet once daily for 4 weeks.

Trial Locations (39)

Unknown

Birmingham

Homewood

Anchorage

Hot Springs

Fresno

San Diego

Denver

New Britain

New Smyrna Beach

Ocala

Orlando

Ormond Beach

Plantation

St. Petersburg

Tallahassee

Tampa

Wellington

Columbus

Roswell

Jeffersonville

Des Moines

Shreveport

Greenbelt

St Louis

Las Vegas

Marlton

Albuquerque

Garden City

Kingston

New York

Orchard Park

Poughkeepsie

Staten Island

Salisbury

Columbus

Bethany

Allentown

Bala-Cynwyd

State College

All Listed Sponsors
collaborator

PriCara, Unit of Ortho-McNeil, Inc.

INDUSTRY

lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00402688 - An Effectiveness and Safety Study for Levofloxacin in Chronic Prostatitis | Biotech Hunter | Biotech Hunter